- Home
- OBIO vs TRUE Comparison
OBIO vs TRUE Comparison
Compare OBIO & TRUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OBIO | TRUE |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 193.0M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | OBIO | TRUE |
|---|---|---|
| Price | $4.67 | $2.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $14.00 | $2.55 |
| AVG Volume (30 Days) | 333.5K | ★ 540.0K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,818,000.00 | ★ $181,222,000.00 |
| Revenue This Year | $36.43 | $9.14 |
| Revenue Next Year | $2.56 | $7.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.46 | 6.18 |
| 52 Week Low | $2.20 | $1.05 |
| 52 Week High | $6.30 | $4.44 |
Technical Indicators
Market Signals| Indicator | OBIO | TRUE |
|---|---|---|
| Relative Strength Index (RSI) | 54.93 | 50.31 |
| Support Level | $4.19 | $2.10 |
| Resistance Level | $5.42 | $2.22 |
| Average True Range (ATR) | 0.35 | 0.07 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 40.82 | 64.71 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.